We are live on ! Find out more
Xponance

Xponance Portfolio holdings

AUM $16.3B Turnover 12.69%
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+29.51%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$16.3B
AUM Growth
+$2.23B
Cap. Flow
-$15.3M
Cap. Flow %
-0.09%
Top 10 Hldgs %
37.34%
Holding
1,883
New
197
Increased
1,009
Reduced
634
Closed
42
Avg Time Held
3.4 years
Top 10 Avg Time Held
4.7 years
Top 20 Avg Time Held
3.3 years

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$149M
2
AMZN icon
Amazon
AMZN
+$128M
3
MSFT icon
Microsoft
MSFT
+$121M
4
ABBV icon
AbbVie
ABBV
+$34.6M
5
COST icon
Costco
COST
+$25M

Sector Composition

Rank Sector Weight
1 Technology 40.2%
2 Communication Services 10.83%
3 Financials 10.29%
4 Consumer Discretionary 9.28%
5 Industrials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LZ icon
1751
LegalZoom.com
LZ
$1.08B
$71.3K ﹤0.01%
11,625
+53
+0.5% +$325
2025 Q4
2 quarters
JBI icon
1752
Janus International
JBI
$572M
$71.2K ﹤0.01%
12,825
+519
+4% +$2.72K
2024 Q4
6 quarters
TALK icon
1753
DELISTED
Talkspace
TALK
$71.2K ﹤0.01%
13,687
+612
+5% +$3.18K
2025 Q3
3 quarters
RUM icon
1754
RUM Group Inc
RUM
$2.34B
$69.9K ﹤0.01%
+11,026
New +$78.3K
2026 Q2
0 quarters
ASPI icon
1755
ASP Isotopes
ASPI
$316M
$69.6K ﹤0.01%
+11,189
New +$65.9K
2026 Q2
0 quarters
TDUP icon
1756
ThredUp
TDUP
$282M
$69K ﹤0.01%
+10,078
New +$47.1K
2026 Q2
0 quarters
ABEV icon
1757
Ambev
ABEV
$50.1B
$68.9K ﹤0.01%
21,934
-332
-1% -$1.04K
2025 Q1
5 quarters
GERN icon
1758
Geron
GERN
$771M
$68.6K ﹤0.01%
53,557
+5,238
+11% +$7.38K
2021 Q2
20 quarters
GRAB icon
1759
Grab
GRAB
$11.7B
$67.4K ﹤0.01%
+17,876
New +$65.1K
2026 Q2
0 quarters
SABR icon
1760
Sabre
SABR
$662M
$67.2K ﹤0.01%
32,169
-998
-3% -$1.75K
2020 Q2
24 quarters
MRVI icon
1761
Maravai LifeSciences
MRVI
$1.04B
$67K ﹤0.01%
+10,733
New +$46.3K
2026 Q2
0 quarters
NB icon
1762
NioCorp Developments
NB
$445M
$66.3K ﹤0.01%
13,757
+3,479
+34% +$19K
2026 Q1
1 quarter
IRWD icon
1763
Ironwood Pharmaceuticals
IRWD
$588M
$65.7K ﹤0.01%
15,599
+1,262
+9% +$4.86K
2024 Q4
6 quarters
BRSP icon
1764
BrightSpire Capital
BRSP
$454M
$64.6K ﹤0.01%
11,848
+199
+2% +$1.14K
2025 Q3
3 quarters
CTMX icon
1765
CytomX Therapeutics
CTMX
$510M
$64K ﹤0.01%
+17,067
New +$65.2K
2026 Q2
0 quarters
CIG icon
1766
CEMIG Preferred Shares
CIG
$6.52B
$63.6K ﹤0.01%
30,298
+3,368
+13% +$7.84K
2024 Q2
8 quarters
HYLN icon
1767
Hyliion Holdings
HYLN
$572M
$63.3K ﹤0.01%
12,153
+850
+8% +$3.54K
2026 Q1
1 quarter
VRRM icon
1768
Verra Mobility
VRRM
$427M
$62.9K ﹤0.01%
14,806
-306
-2% -$3.23K
2024 Q1
9 quarters
NRGV icon
1769
Energy Vault
NRGV
$504M
$62.6K ﹤0.01%
+13,290
New +$59.4K
2026 Q2
0 quarters
RWT icon
1770
Redwood Trust
RWT
$367M
$62K ﹤0.01%
13,072
+749
+6% +$4.07K
2023 Q2
12 quarters
SANA icon
1771
Sana Biotechnology
SANA
$689M
$61.5K ﹤0.01%
17,631
+2,551
+17% +$8.22K
2025 Q2
4 quarters
TBLA icon
1772
Taboola.com
TBLA
$932M
$61.4K ﹤0.01%
+12,281
New +$53.7K
2026 Q2
0 quarters
ACRS icon
1773
Aclaris Therapeutics
ACRS
$512M
$59.6K ﹤0.01%
+11,273
New +$50.3K
2026 Q2
0 quarters
EVH icon
1774
Evolent Health
EVH
$507M
$59.2K ﹤0.01%
10,918
+394
+4% +$1.51K
2026 Q1
1 quarter
OPK icon
1775
Opko Health
OPK
$1.2B
$58.1K ﹤0.01%
38,748
+1,454
+4% +$1.85K
2021 Q2
20 quarters

Similar funds

Xponance's Q2 2026 Portfolio in Review

As of Q2 2026, Xponance held 1,883 positions worth $16.3B, up 16% from $14.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Xponance's Q2 2026 filing shows 197 new, 1,009 increased, 634 reduced and 42 closed positions. Its largest new stake was SpaceX: 114,259 shares worth $19.5M. The largest sale was Apple, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Communication Services and Financials.

  • Xponance's largest Q2 2026 buy was SpaceX: 114,259 shares worth $19.5M.
  • Xponance added most to Micron Technology in Q2 2026, an estimated $80.6M increase.
  • Xponance's biggest Q2 2026 reduction was Apple, cutting an estimated $149M.
  • Xponance fully exited Coterra Energy in Q2 2026, selling an estimated $4.27M.
  • Xponance's ten largest holdings make up 37% of its $16.3B portfolio in Q2 2026.
  • Xponance opened 197 new positions and closed 42 in Q2 2026.
  • Xponance's portfolio value rose 16% quarter-over-quarter to $16.3B.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.